IMIGRANE 10 mg/0.1 ml, solution as a nasal spray 2 ampoules of 0.1 ml
Active ingredients: Sumatriptan
Commercialized according to BDPMDispensing in France: Prescription only
Solution for spraying2 ampoules of 0.1 mlnasale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- IMIGRANE 10 mg/0,1 ml, solution pour pulvérisation nasale
- Pharmaceutical form
- solution pour pulvérisation
- Route of administration
- nasale
- Presentation description
- 2 ampoule(s) en verre de 0,1 ml avec embout nasal polypropylène
- Marketing authorisation holder
- GLAXOSMITHKLINE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Sept 1999
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67153334CIP73433834CIP133400934338342Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SUMATRIPTANsolution | 10,00 mg · une ampoule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.